|  |  | 

India Top Headlines

India Expects US to Ease Export Ban on Vaccine Material Soon: Sources | India News

NEW DELHI: India is hopeful the United States will soon lift a ban on the export of vaccine raw materials that threatens to curb India’s inoculation campaign, two Indian government sources told Reuters on Monday, after the
the foreign ministers of the two nations spoke.
An official said the Biden administration had told India that its request to lift the ban was being considered.
and it would act “as soon as possible.” Indian Foreign Minister Subrahmanyam Jaishankar tweeted that
he and United States Secretary of State Antony Blinken had discussed, among other things, “issues relating to our health
India’s Foreign Ministry declined to give further details. The US State Department confirmed that the two diplomats discussed Covid-19, but did not provide details.
India is currently facing the world’s worst increase in coronavirus infections, prompting an outcry for vaccines.
The country with the largest vaccine production capacity in the world has also halted major exports to meet domestic demand.
Jaishankar confirmed on Monday that the government was trying to address the issue of raw materials, but that it was
It is important that India also meet its export commitments. “I am putting pressure on other countries, particularly some big
countries, saying ‘Look, please keep the flow of raw materials so that vaccines are made in India,’ ”he said, without naming any country.
“Can I … go around the world and tell people that ‘the guys keep their supply chain flowing to me … but I’m not going to give them the vaccine?'”
Washington has invoked the Defense Production Act to preserve vaccine raw materials for its own companies, but the Serum Institute of India (SII), the world’s largest vaccine maker, has said this goes against the global goal. to share vaccines equitably.
When asked about export restrictions, White House press secretary Jen Psaki said that inequalities in access to vaccines were “completely unacceptable” but declined to detail additional US measures to address that. SII is licensed to manufacture the AstraZeneca injection and another developed by the American company Novavax.

Original source